Current therapeutic options for Peyronie's disease

scientific article published in October 2013

Current therapeutic options for Peyronie's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00120-013-3171-Z
P698PubMed publication ID24002219

P2093author name stringW Weidner
A Hauptmann
T Diemer
P2860cites workValidation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie's disease and controls.Q53298881
François de la Peyronie and the disease named after him.Q53480206
Tamoxifen versus placebo in the treatment of Peyronie's disease.Q55033437
ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective StudyQ62660594
A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesisQ72154061
Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcomeQ73112619
Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled studyQ76372661
[Betamethasone versus placebo in Peyronie's disease]Q77584114
Intralesional verapamil prevents the progression of Peyronie's diseaseQ80485567
Penile traction therapy for treatment of Peyronie's disease: a single-center pilot studyQ80974595
An analysis of the natural history of Peyronie's diseaseQ83335142
[Peyronie's disease: diagnostics and therapy]Q84071272
Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's diseaseQ85758154
New surgical treatment for Peyronie diseaseQ93585906
Radiotherapeutic treatment of Peyronie s diseaseQ33508899
CONGENITAL CURVATURE OF THE PHALLUS: REPORT OF THREE CASES WITH DESCRIPTION OF CORRECTIVE OPERATION.Q33971896
Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease.Q34186033
Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized studyQ34403964
A critical analysis of nonsurgical treatment of Peyronie's diseaseQ34525595
Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's diseaseQ34534562
The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's diseaseQ34619272
A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease.Q35009905
Summary of the recommendations on sexual dysfunctions in men.Q36372482
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trialQ36734258
Graft materials in Peyronie's disease surgery: a comprehensive reviewQ36785932
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategyQ37704966
Trauma, gender reassignment, and penile augmentation.Q37730215
The management of Peyronie's disease: evidence-based 2010 guidelinesQ37760270
Current status of the surgical management of Peyronie's diseaseQ37838258
The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomesQ37842789
Review of non-surgical treatment options for Peyronie's diseaseQ37932386
EAU guidelines on penile curvatureQ38015597
Radiation therapy in Peyronie's disease.Q38025221
Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studiesQ38078696
Managing the difficult penile prosthesis patientQ38095623
Drugs of the future for Peyronie's diseaseQ39677371
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's diseaseQ43993189
Diagnostic value of magnetic resonance imaging in Peyronie's disease--a comparison both with palpation and ultrasound in the evaluation of plaque formationQ44324355
The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled studyQ44934972
Tunica albuginea underlap--a new modification of the Nesbit procedure: description of the technique and preliminary resultsQ45059489
Is there a place for conservative treatment in Peyronie's disease?Q46065354
Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled studyQ46130680
Treatment of Peyronie's disease with oral pentoxifyllineQ46937612
The treatment of Peyronie's disease with tamoxifenQ46941711
Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screeningQ50147740
Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.Q53116615
Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.Q53118860
A new, innovative, lengthening surgical procedure for Peyronie's disease by penile prosthesis implantation with double dorsal-ventral patch graft: the "sliding technique".Q53133398
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.Q53193957
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.Q53230701
P433issue10
P407language of work or nameGermanQ188
P304page(s)1406-1415
P577publication date2013-10-01
P1433published inDer Urologe. Ausg. AQ27713718
P1476titleCurrent therapeutic options for Peyronie's disease
P478volume52

Search more.